Opinion
Civil Action 23-mc-111
09-22-2023
TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA AMERICAS HOLDINGS, INC., TAKEDA PHARMACEUTICALS U.S.A. INC., and TAKEDA DEVELOPMENT CENTER AMERICAS, INC., Plaintiff, v. CAREMARK RX, LLC, Defendant.
ORDER
GERALD J. PAPPERT, J.
AND NOW, this 22nd day of September, 2023, upon consideration of Takeda's Motion to Compel (ECF No. 1, 2), Caremark's Response in Opposition (ECF No. 11), and Takeda's Reply (ECF No. 14), it is hereby ORDERED that Takeda's Motion to Compel Caremark to comply with its Rule 45 subpoena is GRANTED. Caremark must comply by October 6, 2023.